title: Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide.
authors.affiliation: Third Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Yamaguchi, 755-8505, Japan, yujirit@yamaguchi-u.ac.jp.
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Yujiri
authors.forename: Mayumi
authors.initials: M
authors.lastname: Tanaka
authors.forename: Akihiko
authors.initials: A
authors.lastname: Taguchi
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Yukinori
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Yukio
authors.initials: Y
authors.lastname: Tanizawa
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage / Q000009:adverse effects; D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000097:blood*; D006510:Hepatitis B Antibodies / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage / Q000009:adverse effects; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D010087:Oxides; D000077237:Arsenic Trioxide